Suga M, Kida S, Mizutani Y, Kogue Y, Yamaguchi Y, Ikeda S, Kawamoto R, Tachikawa M, Seto T, Takekawa H, Maehara Y, Shibata K, Tsutsumi K, Murakami H, Mizuta E, Yoshihara K, Yoshihara S, Nakamae H, Nakao T, Inoue M, Ueda S, Kosugi S, Ueda Y, Kato H, Kusakabe S, Kasahara H, Hino A, Fujita J, Ueda T, Ichii M, Fukushima K, Hosen N. Cord blood-derived natural killer cells engineered with a novel, high affinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expression. Haematologica; https://doi.org/10.3324/haematol.2026.301327 [Early view].